Thalidomide in small cell lung cancer: wrong drug or wrong disease?

Détails

Ressource 1Télécharger: REF.pdf (67.38 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_0B64E30373A6
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
Thalidomide in small cell lung cancer: wrong drug or wrong disease?
Périodique
Journal of the National Cancer Institute
Auteur⸱e⸱s
Rüegg C., Peters S.
ISSN
1460-2105[electronic], 0027-8874[linking]
Statut éditorial
Publié
Date de publication
2009
Volume
101
Numéro
15
Pages
1034-1035
Langue
anglais
Mots-clé
Angiogenesis Inhibitors/administration &amp, dosage, Angiogenesis Inhibitors/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Brain Neoplasms/prevention &amp, control, Brain Neoplasms/secondary, Clinical Trials, Phase III as Topic, Cranial Irradiation, Humans, Lung Neoplasms/drug therapy, Neoplasm Recurrence, Local/prevention &amp, control, Radiotherapy, Adjuvant, Randomized Controlled Trials as Topic, Small Cell Lung Carcinoma/drug therapy, Small Cell Lung Carcinoma/prevention &amp, control, Thalidomide/administration &amp, dosage, Thalidomide/therapeutic use, Treatment Failure, Treatment Outcome, Tumor Markers, Biological/metabolism
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/07/2009 9:10
Dernière modification de la notice
14/02/2022 8:53
Données d'usage